Evelo Biosciences Inc

Great News! Now you can buy fractional shares of Evelo Biosciences Inc

What is Fractional Shares?

Fractional shares are pieces of one full share of a company or exchange-traded fund (ETF).

In INDmoney, you can buy Evelo Biosciences Inc stock in any dollar amount, or any other stock you want.

$10

$50

$100

EVLO

Evelo Biosciences Inc (EVLO)

Q: What is Evelo Biosciences Inc (EVLO) share price today?

Evelo Biosciences Inc (EVLO) share price today is $5.52

Q: Can Indians buy Evelo Biosciences Inc (EVLO) shares?

Yes, Indians can buy Evelo Biosciences Inc (EVLO) shares. As per RBI rule, an Indian citizen can invest 250,000 dollars a year in foreign markets.

Q: How can I buy Evelo Biosciences Inc (EVLO) shares from India?

Three ways to invest in Evelo Biosciences Inc (EVLO) stocks from India are 1.Investment through apps: INDmoney is one of the leading apps that help you invest in Evelo Biosciences Inc (EVLO) stocks from India 2.Investment through Indian brokers tied up with a foreign broker 3.Investment by opening an account with a Foreign broker

Q: Can Fractional shares of Evelo Biosciences Inc (EVLO) be purchased?

You can buy just a fraction of Evelo Biosciences Inc (EVLO) shares.

Q: What are the documents required to start investing in Evelo Biosciences Inc (EVLO) stocks?

You will need a proof of Identification (PAN, Aadhaar etc) and proof of address (Aadhaar, Voter ID etc) to invest in Evelo Biosciences Inc (EVLO) stocks . The entire process is paperless and can be completed seamlessly.

$5.521.25%▲

Key Stats

Open	$5.63
Today Low/High	$5.18 / $5.63
52 Week Low/High	$5.15 / $19.93
Market Cap	$310.6M

Company Details

Evelo Biosciences is a clinical stage biotechnology company developing orally delivered product candidates that are designed to act on the small intestinal axis, SINTAX™, with systemic therapeutic effects. SINTAX plays a central role in governing the immune, metabolic, and neurological systems. The Company's first product candidates are pharmaceutical preparations of single strains of microbes selected for the potential to offer defined pharmacological properties. Evelo's therapies have the potential to be effective, safe, and affordable medicines to improve the lives of people with inflammatory diseases and cancer.